Company intelligence / Profile preview
Salspera
Cambridge, Massachusetts, United Statessalspera.com ↗
- Ownership
- Private
- Employees
- ~2
- Development stage
- Phase 2
01
Overview
Salspera has developed a proprietary platform of orally administered microbial immunotherapies targeting solid tumors. The company’s therapies are in clinical development and aim to address high unmet medical needs in oncology by leveraging the immune-modulating properties of the microbiome. Specific clinical results or trial data are not detailed in available sources[1][2].
- Therapeutic areas
- Oncology
- Modalities
- Microbial immunotherapies (oral microbiome-based immunotherapy)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Salspera.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Salspera.